Diversity, equity, and inclusion are critical to reducing cancer disparities. All people should have the ability to benefit from advancements in the prevention, diagnosis, and treatment of cancer. Our aim is to present this program that will embrace and be inclusive of every community touched by cancer, actively working towards ending cancer disparities.

We believe that a major sector who can benefit in conversations that prompt fundamental change in cancer is the Primary Care physician group, a gatekeeper in many paths to diagnosis, intervention, and managed care.

In partnership with this sector of medicine, we can reach communities that have been disproportionately burdened by cancer and who experience greater obstacles to cancer prevention, early detection, treatment, and survival.

Our evening program focuses on developing strong relational patterns and pathways of encouraging conversations on the prevention, diagnosis, and treatment of cancer, which will bring members of the Primary Care community together with members of the oncology multidisciplinary care teams.

Total Health's 2024 Community Oncology Educational Discussion Series (COEDS) consists of educational activities designed to meet the educational needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of breast cancer. The agenda is comprised of multidisciplinary, case-based presentations that break down the most clinically relevant information applicable to community care. This accredited meeting is hosted as an in-person conference only.

Total Health's 2023 Community Oncology Educational Discussion (COEDS) Dinner Program with a focus in Breast Cancer Diagnostics consisted of educational activities designed to meet the educational needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of breast cancer.

The 9th Annual West Oncology Conference served as a valuable forum for presenting and discussing new research findings in oncology education.

Learners were provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting was an in-person conference with on-demand access for registered attendees.